BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31958356)

  • 21. Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.
    Berra G; Huszti E; Levy L; Kawashima M; Fuchs E; Renaud-Picard B; Riddell P; Dias O; Rajagopala S; Ulahannan A; Ghany R; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2022 May; 41(5):599-607. PubMed ID: 35351385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
    Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
    PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
    Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
    Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lung allograft dysfunction subtype analysis by computed tomography volumetry.
    Peräkylä LH; Raivio PM; Kesävuori RI; Piilonen AK; Stark CK; Halme MK; Nykänen AI
    Clin Transplant; 2022 Jan; 36(1):e14507. PubMed ID: 34634164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
    Verleden GM; Godinas L; Vos R; Verleden SE
    Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
    Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
    Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study.
    Davidsen JR; Laursen CB; Højlund M; Lund TK; Jeschke KN; Iversen M; Kalhauge A; Bendstrup E; Carlsen J; Perch M; Henriksen DP; Schultz HHL
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33807615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of total lymphoid irradiation in different chronic lung allograft dysfunction phenotypes.
    Geng-Cahuayme AAA; Sáez-Giménez B; Altabas-González M; Vázquez-Varela M; Berastegui-Garcia C; Giralt-López de Sagredo J; Zapata-Ortega M; Recalde-Vizcay E; López-Meseguer M
    Clin Transplant; 2023 Feb; 37(2):e14891. PubMed ID: 36583252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lung allograft dysfunction phenotypes and treatment.
    Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
    J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
    Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
    Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.
    Veraar C; Kliman J; Benazzo A; Oberndorfer F; Laggner M; Hacker P; Raunegger T; Janik S; Jaksch P; Klepetko W; Ankersmit HJ; Moser B
    Sci Rep; 2021 Mar; 11(1):6799. PubMed ID: 33762606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.
    Berastegui C; Gómez-Ollés S; Mendoza-Valderrey A; Pereira-Veiga T; Culebras M; Monforte V; Saez B; López-Meseguer M; Sintes-Permanyer H; Ruiz de Miguel V; Bravo C; Sacanell J; Ramon MA; Romero L; Deu M; Román A
    PLoS One; 2020; 15(1):e0226488. PubMed ID: 31929536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotyping Chronic Lung Allograft Dysfunction Using Body Plethysmography and Computed Tomography.
    Suhling H; Dettmer S; Greer M; Fuehner T; Avsar M; Haverich A; Welte T; Gottlieb J
    Am J Transplant; 2016 Nov; 16(11):3163-3170. PubMed ID: 27203799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.